Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Comment by LithLoveron Jan 17, 2022 4:07pm
129 Views
Post# 34325924

RE:RE:No sellers under 0.30

RE:RE:No sellers under 0.30The job of the market maker is just that.  To ensure that investors are able to buy and sell shares.  When no shares or very limited shares are avaiable they still need to make a market. 

When you see situations like I posted it just shows there is very limited shares being sold at this level but the market makers still needs to post shares avalable so in this case when amounts are so obvious its just to point out the thin asks.

Nothing more just pointing out thin asks on a slow day.  

There is also only 1 month left on the warrant extension for Hampton where they extended warrants of $0.56 to Feb 19, 2022.

Toronto, Ontario--(Newsfile Corp. - August 5, 2021) - StageZero Life Sciences, Ltd. (TSX: SZLS) ("StageZero" or the "Company") announces that it is extending the expiry date ("Warrant Extension") of 202,343 common share purchase warrants (the "Warrants") issued to a broker in connection with the Company's convertible debenture financing closed February 19, 2020.

The Company and holder of the Warrants have agreed to the Warrant Extension whereby the current expiry of the Warrants being August 19, 2021, will be extended by six (6) months to February 19, 2022. All other terms of the Warrants, including the exercise price of $0.56 per common share, will remain unchanged. None of the Warrants are held by insiders of the Company. The Warrant Extension will be effective August 19, 2021, subject to approval of the Toronto Stock Exchange.



IainCaimbeul wrote: You think it is a conspiracy? Guffaw guffaw guffaw.  This pig will be stuck until at least end of March unless there ia some outstanding news which based on past performance is highly unlikely.

Now, cue mykndsrn for some sort of banal snotty remark.

LithLover wrote: Are we to beleive there are no sellers at 0.275 or 0.285 but yet identical amounts for sale at 0.28 and 0.29.  Sure OK.  



Level two quotes - Ask
Ask Price Number of Shares
0.280 9,000
 
9,000 shares
0.290 9,000




<< Previous
Bullboard Posts
Next >>